Published in Clin Ther on August 12, 2011
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease. Aliment Pharmacol Ther (2013) 0.92
The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries. BMC Gastroenterol (2013) 0.91
Estimation of average diagnosis and treatment costs of hepatitis C. Gastroenterol Hepatol Bed Bench (2012) 0.85
The burden of untreated hepatitis C virus infection: a US patients' perspective. Dig Dis Sci (2012) 0.79
The societal burden of chronic liver diseases: results from the COME study. BMJ Open Gastroenterol (2015) 0.77
Surveillance system for hepatitis C infection: A practical approach. Int J Prev Med (2012) 0.77
Efficacy and safety of low-dose peginterferon alpha-2a plus ribavirin on chronic hepatitis C. Gastroenterol Res Pract (2012) 0.75
Cost-effectiveness of IL28Β genotype-guided protease inhibitor triple therapy versus standard of care treatment in patients with hepatitis C genotypes 2 or 3 infection. Public Health Genomics (2014) 0.75
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol (2010) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. J Manag Care Pharm (2008) 2.16
Ammonia levels and the severity of hepatic encephalopathy. Am J Med (2003) 2.14
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ (2010) 1.72
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol (2005) 1.61
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology (2010) 1.56
Treating hepatitis C in the prison population is cost-saving. Hepatology (2008) 1.50
Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol (2009) 1.42
Kidney transplantation threshold in patients with hepatitis C: a decision analysis model. Transplantation (2015) 1.38
Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci (2008) 1.38
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
Treatment of hepatitis C. Am J Med (2005) 1.35
Design parameters of a miniaturized piezoelectric underwater acoustic transmitter. Sensors (Basel) (2012) 1.33
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg (2010) 1.28
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation (2007) 1.26
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology (2013) 1.21
Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl (2007) 1.20
Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol (2009) 1.17
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg (2003) 1.15
An efficient photocatalyst structure: TiO(2)(B) nanofibers with a shell of anatase nanocrystals. J Am Chem Soc (2009) 1.15
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl (2004) 1.12
Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nurs Res (2008) 1.11
Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells. PLoS One (2010) 1.10
The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg (2013) 1.08
The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States. Hepatology (2013) 1.08
Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci (2005) 1.03
The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value Health (2012) 1.01
Pregnancy and cirrhosis. Liver Transpl (2008) 1.01
The epidemiologic burden of hepatitis C virus infection in Latin America . Ann Hepatol (2012) 1.00
A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl (2003) 1.00
Pregnancy and liver transplantation. Liver Int (2008) 1.00
Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. Liver Int (2010) 1.00
The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium (2004) 0.99
Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int J Cancer (2009) 0.99
Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes (2012) 0.98
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis. Liver Int (2007) 0.98
Degradation of carbazole by microbial cells immobilized in magnetic gellan gum gel beads. Appl Environ Microbiol (2007) 0.98
Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2011) 0.98
Enhanced performance of air-cathode two-chamber microbial fuel cells with high-pH anode and low-pH cathode. Bioresour Technol (2010) 0.97
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
Health-related quality of life after liver transplantation for adult recipients. Liver Transpl (2009) 0.96
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg (2011) 0.95
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J Med Econ (2011) 0.94
Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion. Mol Cell Endocrinol (2012) 0.93
Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol (2002) 0.93
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Dig Dis Sci (2009) 0.93
The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients. Liver Int (2009) 0.93
Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep (2010) 0.92
New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg (2002) 0.91
Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol (2004) 0.91
Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc (2009) 0.91
Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model. Appl Health Econ Health Policy (2013) 0.91
Primary nonadherence to statin medications in a managed care organization. J Manag Care Pharm (2013) 0.90
Modeling for gellan gum production by Sphingomonas paucimobilis ATCC 31461 in a simplified medium. Appl Environ Microbiol (2006) 0.90
Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J (2003) 0.89
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci (2014) 0.89
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial. Can J Cardiol (2007) 0.89
Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg (2011) 0.89
Structural frameworks and key model parameters in cost-effectiveness analyses for current and future treatments of chronic hepatitis C. Value Health (2011) 0.87
Presence and predictors of hepatitis C virus RNA in the semen of homeless men. Biol Res Nurs (2002) 0.87
Magnetic nano-beads based separation combined with propidium monoazide treatment and multiplex PCR assay for simultaneous detection of viable Salmonella Typhimurium, Escherichia coli O157:H7 and Listeria monocytogenes in food products. Food Microbiol (2013) 0.87
The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes. Eur J Gastroenterol Hepatol (2012) 0.86
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatol Int (2015) 0.86
Assessing the relationship between computational speed and precision: a case study comparing an interpreted versus compiled programming language using a stochastic simulation model in diabetes care. Pharmacoeconomics (2010) 0.85
Deproteinization of gellan gum produced by Sphingomonas paucimobilis ATCC 31461. J Biotechnol (2006) 0.85
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer (2014) 0.85
Complications of cirrhosis. Dis Mon (2008) 0.85
Liver transplantation in the era of model for end-stage liver disease. Liver Int (2004) 0.85
Alumina nanofibers grafted with functional groups: a new design in efficient sorbents for removal of toxic contaminants from water. Water Res (2009) 0.85
Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis. Liver Int (2014) 0.85
Scalable microbial fuel cell (MFC) stack for continuous real wastewater treatment. Bioresour Technol (2011) 0.84
Humic substance-mediated reduction of iron(III) oxides and degradation of 2,4-D by an alkaliphilic bacterium, Corynebacterium humireducens MFC-5. Microb Biotechnol (2012) 0.84
The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health (2003) 0.83
Presence of mutation m.14484T>C in a Chinese family with maternally inherited essential hypertension but no expression of LHON. Biochim Biophys Acta (2012) 0.83
Primary prevention of cirrhosis. Public health strategies that can make a difference. Postgrad Med (2004) 0.83
Sorption induced structural deformation of sodium hexa-titanate nanofibers and their ability to selectively trap radioactive Ra(II) ions from water. Phys Chem Chem Phys (2009) 0.83
Extracellular quinones affecting methane production and methanogenic community in paddy soil. Microb Ecol (2013) 0.82
Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma. Clin Gastroenterol Hepatol (2009) 0.82
Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B. Appl Health Econ Health Policy (2008) 0.82
Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review. Exp Clin Transplant (2012) 0.82
Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis. Exp Clin Transplant (2013) 0.82
Patients with nodular regenerative hyperplasia should be considered for hepatocellular carcinoma screening. Hepatol Res (2013) 0.81
Trauma evaluation of patients with chest injury in the 2008 earthquake of Wenchuan, Sechuan, China. World J Surg (2010) 0.81
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatol Int (2010) 0.81
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
Deciding liver transplant candidacy: tools of the trade. Liver Int (2008) 0.80